New Leukemia Drug Combo Shows 90% Response in Trial

A three-drug combination therapy achieved nearly 90% response rates in patients with a hard-to-treat form of leukemia that had returned after standard treatments failed.

The treatment worked fast and was well tolerated, offering new hope for people facing limited options.